Status:
NOT_YET_RECRUITING
Hematological Indices in Pediatric Diagnosed with Familial Mediterranean Fever
Lead Sponsor:
Assiut University
Conditions:
Familial Mediterranean Fever (FMF )
Eligibility:
All Genders
1-18 years
Brief Summary
To investigate the relationship between the hematological indices and subclinical inflammation in FMF patients during their attack-free period, additionally this study aims to assess the potential of ...
Detailed Description
Familial Mediterranean fever (FMF) is the most common hereditary auto inflammatory disease in the world. FMF is caused by gain of function mutations in the MEFV gene, which encodes a protein called py...
Eligibility Criteria
Inclusion
- Age at enrollment less than18 years.
- Both sexes.
- Diagnosed as familial Mediterranean fever according to Tel-Hashomer criteria in pediatrics and Eurofever /PRINTO criteria
Exclusion
- 1- Patients with acute or chronic active infections. 2- Patients with pre-existing illness as chronic lung, liver or renal diseases. 3- Patients with diabetes mellitus, atherosclerotic vascular disease. 4- Patients with malignancy
- \-
Key Trial Info
Start Date :
October 13 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2026
Estimated Enrollment :
93 Patients enrolled
Trial Details
Trial ID
NCT06583304
Start Date
October 13 2024
End Date
March 31 2026
Last Update
September 4 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.